Minerva Neurosciences reported $1000 in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Adma Biologics ADMA:US USD 20K 0
ALKERMES ALKS:US USD 1.69M 1000
AstraZeneca AZN:LN USD 387M 0
Bristol Myers Squibb BMY:US USD 292M 0
Eli Lilly And LLY:US USD 594.1M 0
Esperion Therapeutics ESPR:US USD 72K 7K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Halozyme Therapeutics HALO:US USD 135K 3K
IONIS PHARMACEUT IONS:US USD 142K 0
Marinus Pharmaceuticals MRNS:US USD 37K 0
Minerva Neurosciences NERV:US USD 1000 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 878.25M 11.75M
Novavax NVAX:US USD 792K 4K
Takeda 4502:JP JPY 1.68T 53M
Vanda Pharmaceuticals VNDA:US USD 57K 0